Krsnaa Diagnostics shares touched 52-week high of Rs 901.10, rising more than 3 percent in the early on October 11 after company signed agreements to provide radiology and pathology services.
At 09:20am, Krsnaa Diagnostics was quoting at Rs 890.05, up Rs 29.55, or 3.43 percent, on the BSE, and extended the gains on the fourth consecutive day.
The company has received the signed agreement from the Medical Superintendent, Sadar Hospital, Ranchi, Jharkhand for commission, install, operate and maintain the Radiology Services (CT and MRI) on public private partnership (PP) basis at Sadar Hospital, Purulia Road, Ranchi.
Also, the company has received the signed agreement from the Ranchi Institute of Neuro-Psychiatry & Allied Services (RINPAS), for supply, install, commission, operate and maintain the Radiology Center (CT & MRI) and Pathology Laboratory services on PPP basis at Ranchi Institute of neuro-psychiatry & allied sciences, Government of Jharkhand, India.
Catch all the market action on our live blog
In September, the company announced plans to acquire a 23.53 percent stake in start-up Apulki Healthcare for exclusive rights to provide diagnostics services.
The share touched a 52-week high of Rs 887.95 and a 52-week low of Rs 527.55 on 23 September, 2024 and 05 June, 2024, respectively.
Currently, the stock is trading 3.09 percent below its 52-week high and 63.11 percent above its 52-week low.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
